KevinAWalterMD
Neurosurgery • Rochester, NYBrain & Spinal Tumor, Neurosurgical Spine Surgery
Professor, Neurosurgery, Oncology, and Orthopedics, University of Rochester School of Medicine & Dentistry
Dr. Walter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-276-3581Fax+1 585-276-2892
Summary
- Kevin Walter, MD, is a neurosurgeon based in Rochester, NY, with subspecialties in brain and spinal tumors and neurosurgical spine surgery. He completed his education and residency at Johns Hopkins University School of Medicine and is experienced in glioblastoma, gliomas, neurosurgical oncology, minimally invasive spine surgery, and skull base surgery. Dr. Walter has contributed to numerous publications in reputable journals, focusing on topics such as the treatment of intracranial metastasis and high-grade glioma among others. He has participated in a clinical trial related to a drug for Newly Diagnosed GBM Brain Cancer. He has been honored with CMS Meaningful Use Stage 1 Certification and is a Fellow of the American Association of Neurological Surgeons.
Education & Training
Johns Hopkins UniversityResidency, Neurological Surgery, 1996 - 2002- Johns Hopkins University/Bayview Medical CenterInternship, Transitional Year, 1995 - 1996
- Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
NY State Medical License 2006 - 2026
MD State Medical License 1999 - 2015
PA State Medical License 2002 - 2014- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FAANS) American Association of Neurological Surgeons
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- 195 citationsFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29 - 63 citationsTranscriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genesRomane Auvergne, Fraser J. Sim, Su Wang, Devin Chandler-Militello, Jaclyn E. Burch
Cell Reports. 2013-06-27 - 25 citationsRisk Factors Associated with Readmission and Reoperation in Patients Undergoing Spine Surgery.Keaton Piper, Ian A DeAndrea-Lazarus, Hanna Algattas, Kristopher T. Kimmell, James Towner
World Neurosurgery. 2017-11-01
Press Mentions
Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
Grant Support
- ClinicalNational Institute Of Neurological Disorders And Stroke2008–2010
- Gene Expression In Brain Tumor AngiogenesisNational Institute Of Neurological Disorders And Stroke2008
- ClinicalNational Institute Of Neurological Disorders And Stroke2006–2007
- Gene Expression In Brain Tumor AngiogenesisNational Institute Of Neurological Disorders And Stroke2004–2007
- Antisf/Hgf Ribozyme Transfer To Brain Tumors In VivoNational Cancer Institute1999–2000
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
